US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

45.97

+0.26860.59%

Post-market: 45.970.00000.00%16:15 EDT

Volume:2K

Turnover:106.96K

Market Cap:126.73M

PE:- -

High:46.65

Open:46.65

Low:45.51

Close:45.70

52wk High:48.78

52wk Low:27.68

Shares:2.76M

Float Shares:2.76M

Volume Ratio:0.85

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Takeda receives FDA approval of NDA for Mimrylo

Labcorp to Present at Morgan Stanley Healthcare Conference

Roche receives FDA approval for companion diagnostic tests for Ziihera

Top Midday Decliners

MT Newswires Live

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Spyre Therapeutics falls -13.2%

Spyre Therapeutics Down over 12%, on Pace for Largest Percent Decrease Since June 2024

U.S. Stocks on the MOVE-Semtech, Donaldson, Meta

Spyre Therapeutics (SYRE) Gets a Buy from LifeSci Capital

Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)

Spyre Therapeutics Reports Phase 2 Skyway RA Data for Spy072 Shows Statistically Significant Benefit vs Placebo

Spyre Therapeutics Shares Down 12.4% Premarket After Co's Experimental Drug Fails to Meet Threshold for Monotherapy Development in Rheumatoid Arthritis

THOMSON REUTERS

Circio and Full Circles join forces on non-viral in vivo cell therapy platform

Spyre Therapeutics Inc : Btig Cuts Target Price to $121 from $132

THOMSON REUTERS

Stocks to Watch: Intuit, Spyre Therapeutics, Zoom Communications, nCino

Spyre Therapeutics Stock (SYRE) Tumbles 14% in After-Hours – Here’s What Spooked Investors

Spyre Therapeutics Won't Prioritize Rheumatoid Arthritis Monotherapy After Trial

Spyre Therapeutics announces results from RA sub-study of SKYWAY basket trial

Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-Study of the Skyway Phase 2 Trial of Spy072

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LFSC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":45.9664,"timestamp":1788379200000,"preClose":45.6978,"halted":0,"volume":2330,"hourTrading":{"tag":"盘后","latestPrice":45.9664,"preClose":45.9664,"latestTime":"16:15 EDT","volume":10,"amount":459.664,"timestamp":1788380100277,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005877744661668598,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Post-Mkt","change":0.2686,"latestTime":"09-02 19:21:51 EDT","open":46.65,"high":46.65,"low":45.51,"amount":106959,"amplitude":0.024946,"askPrice":68.32,"askSize":100,"bidPrice":45.14,"bidSize":11,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":45.6978,"sharesOutstanding":2657035,"nav":45.8,"aum":126272203,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.9664,"preClose":45.9664,"latestTime":"16:15 EDT","volume":10,"amount":459.664,"timestamp":1788380100277,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.854983},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.854983,"shares":2757035,"dividePrice":0,"high":46.65,"amplitude":0.024946,"preClose":45.6978,"low":45.51,"week52Low":27.6794,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":45.9664,"committee":-0.801802,"eps":0,"divideRate":0,"volume":2330,"delay":0,"ttmEps":0,"open":46.65,"prevYearClose":36.6147,"prevWeekClose":45.9566,"prevMonthClose":45.79,"prevQuarterClose":45.2033,"fiveDayClose":47.5848,"twentyDayClose":47.4383,"sixtyDayClose":37.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","MRNX","IYH","FRTY","GNMX","MRNY","LABU","GDOC","IBB","MEDI","NVIB","PSCH","LFSC","BK4007","BBP","BK4588","BK4585","RSPH","BMED","TECB","TBXU","IDNA","TAK","SYNB","XLVX","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009682","title":"Labcorp to Present at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662009682?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:36","pubTimestamp":1787924191,"startTime":"0","endTime":"0","summary":"Labcorp Holdings ( ($LH) ) has issued an announcement. Labcorp Holdings Inc., a global leader in diagnostics and drug development laboratory servic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FBT","LABU","XBI","LFSC","BK4137","BMED","HCSG","XLV","LU0128526141.USD","BK4588","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","MRNX","IEIH","IYH","FRTY","GNMX","MRNY","LABU","RHHBY","GDOC","IBB","MEDI","NVIB","PSCH","LFSC","BK4007","BBP","BK4588","BK4585","RSPH","BMED","TECB","TBXU","IDNA","03165","HRTS","SYNB","XLVX","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749365","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749365","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749365?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:23","pubTimestamp":1787768612,"startTime":"0","endTime":"0","summary":"Electromed  Chief Executive Jim Cunniff plans to retire around April 2 after serving as president and CEO since 2023, it said late Tuesday, adding that the board plans to search for his successor.Shares declined 18%, with intraday trading volume rising to over 229,000 from a daily average of about 89,000.Greenland Mines  shares slumped 43% amid heavy trading after the company said it priced its public offering of 4 million shares for gross proceeds of about $20 million.Intraday trading volume catapulted to over 2.09 million from a daily average of about 174,000.Spyre Therapeutics  said late Tuesday its experimental rheumatoid arthritis drug SPY072 failed to meet the company's internal performance threshold needed to justify further stand-alone development, prompting a halt of its monotherapy RA program.Shares dropped 14% as intraday trading volume rose to over 1.96 million from a daily average of about 1.25 million.Price: 32.20, Change: -7.14, Percent Change: -18.15","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LFSC","SYRE","BK4139","BK4082","GRML","ELMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","CANC","IEIH","RVMD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0009354923.USD","PTH","MEDI","BBP","BK4585","IE00BJJMRZ35.SGD","LABU","MRNX","TBXU","IE00B4R5TH58.HKD","NVIB","IE0009355771.USD","IE00BFTCPJ56.SGD","RSPH","PSCH","GNMX","LFSC","LU0320765992.SGD","BK4588","IE0002141913.USD","TECB","IYH","XLVX","IDNA","PINK","BMED","SYNB","IBB","LU0889565916.HKD","FRTY","BK4139","GDOC","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","LU0109394709.USD","PINK","MEDI","IYH","BK4585","MRNX","BK4588","IE00B2B36J28.USD","RVMD","LFSC","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","GNMX","LABU","IEIH","BBP","LU0320765992.SGD","XLVX","IE0009355771.USD","IBB","FRTY","NVIB","SYNB","BBH","TBXU","IDNA","MRNY","CANC","IE0009354923.USD","LU0889565916.HKD","PTH","GDOC","PSCH","TECB","IE00BJT1NW94.SGD","RSPH","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662474530","title":"Spyre Therapeutics falls -13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662474530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662474530?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:05","pubTimestamp":1787760324,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics (SYRE) is down -13.2%, or -$14.16 to $93.20. Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-falls-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-falls-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","LFSC","SYRE","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662104247","title":"Spyre Therapeutics Down over 12%, on Pace for Largest Percent Decrease Since June 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2662104247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662104247?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:35","pubTimestamp":1787754900,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics, Inc  is currently at $94.12, down $13.24 or 12.33%--Would be lowest close since July 16, 2026, when it closed at $94.12--On pace for largest percent decrease since June 17, 2024, when it fell 19.3%--Snaps a two day winning streak--Down 4.28% month-to-date; on pace for worst month since April 2025, when it fell 5.61%--Up 187.3% year-to-date--Down 68.6% from its all-time closing high of $299.75 on April 8, 2016--Up 449.12% from 52 weeks ago , when it closed at $17.14--Down 13.59% from its 52-week closing high of $108.92 on Aug. 19, 2026--Up 535.09% from its 52-week closing low of $14.82 on Sept. 16, 2025--Traded as low as $90.60; lowest intraday level since July 7, 2026, when it hit $86.60--Down 15.61% at today's intraday low; largest intraday percent decrease since June 24, 2026, when it fell as much as 15.87%All data as of 10:32:24 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4007","LFSC","SYRE","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662171137","title":"U.S. Stocks on the MOVE-Semtech, Donaldson, Meta","url":"https://stock-news.laohu8.com/highlight/detail?id=2662171137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662171137?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:31","pubTimestamp":1787747476,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Semtech, Donaldson, MetaAugust 26 (Reuters)-U.S. stock index futures were little changed on Wednesday as investors stayed cautious ahead of AI bellwether Nvidia's earnings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL6N44N0NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250843.SGD","07388","LU2237957902.USD","LU0724617625.USD","LU0689472784.USD","PLTL","IE0004445015.USD","IE00B19Z8W00.USD","IE00BZ199S13.USD","LU0444973449.USD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU0211327993.USD","LU0133085943.USD","LU0943347566.SGD","LU1861559042.SGD","LU0158827948.USD","ROM","LU2471134796.USD","LU1670628061.USD","LU2394011477.USD","ADBG","IE00BQXX3F31.USD","LU0477156953.USD","IE0009356076.USD","LU0096364046.USD","LU2491050154.USD","LU0820561818.USD","NVC","IE0000B7K699.USD","IE00BMPRXN33.USD","LU0426417589.USD","SG9999014567.USD","LU0077335932.USD","LU0861579265.USD","BK4561","LU0124676726.USD","LU1564329461.SGD","PLTW","EFIV","LU1046421795.USD","LU1989764664.SGD","IE000ITXATA3.USD","SG9999014914.USD","LU0787776722.HKD","LU2430703095.HKD","PLTZ","LU0965509101.SGD","JGRO","LU2264538146.SGD","LU0006306889.USD","LU2471134523.USD","METW","SOXX","BK4532","LU0640476718.USD","USD","LU2286300806.USD","NVDS.UK","LU0203201768.USD","LU1236620750.USD","SGXZ23171101.USD","LU2089985449.USD","LU2191332357.HKD","LU2602419157.SGD","LU1242518857.USD","LU1983299246.USD","LU0823416689.USD","LU0106261612.USD","LU2433249047.HKD","LU1979441026.SGD","LU0719512351.SGD","LU0053666078.USD","LU0882574139.USD","ESUM","LU0511384066.AUD","IE00B1XK9C88.USD","IE000SO60NU8.SGD","NVDG","LU1791710582.SGD","IE000F7OJYX1.SGD","LU1674673691.USD","LU2764263203.CNY","IE00BFSS7M15.SGD","SMTC","LU0187121727.USD","LU0348723411.USD","LU0109391861.USD","TEK","BK4162","LU0950375773.USD","LU1267930490.SGD","ADBU","LU0061474960.USD","LU2125154778.USD","SOCL","LU0234572021.USD","LU2361044865.SGD","LU0267386448.USD","LU1720051017.SGD","IE00BMPRXR70.SGD","LU2764262908.HKD","LU1066051498.USD","LU0417517546.SGD","LU0158827781.USD","AIPI","VT","LU2250418816.HKD","LU2326559502.SGD","LU0057025933.USD","LU1732799900.SGD","OGIG","TTXU","LU0211328371.USD","LU2491049909.HKD","BK4200","LU2404859741.USD","FAI","GB00B4LPDJ14.GBP","IE00BFSS8Q28.SGD","LU0114720955.EUR","VOX","BK4082","IE00B3M56506.USD","LU2092627202.USD","LU0211331839.USD","LU1778281490.HKD","LU0061474705.USD","LU1923622614.USD","LU0203347892.USD","LU2097344357.USD","METG","LU0265550359.USD","LU0690374961.EUR","LU2083900584.USD","LU3102509885.SGD","SYRE","LU1917777945.USD","LU0476273544.USD","LU2999663052.SGD","LU2065170008.USD","LU2125909759.SGD","SG9999018865.SGD","LU1935042991.SGD","LU2362540622.SGD","LU0345774391.USD","LU1839511570.USD","LU0965509283.SGD","CRMG","LU2242649171.HKD","LU0345769128.USD","LU1732800096.USD","IE00BYQQ9H92.USD","BK4612","LU0198837287.USD","BK4581","SOXQ","LU0130518102.USD","LU2746668974.SGD","LU1699723380.USD","SGXZ80539844.SGD","HK0000304797.USD","LU0210536198.USD","IE00B19Z8X17.USD","LU1923623000.USD","LU0494093205.USD","LU0823417653.USD","LU0965509010.AUD","LU0353189763.USD","LU1127390331.HKD","LU2100268510.USD","IE000Q6AESB8.SGD","IE00BKVL7J92.USD","LU1642822529.SGD","INTU","LU0823434583.USD","BK4139","PLTU","LU0784385840.USD","SG9999013999.USD","BK4141","BK4525","BK4592","LU0823434740.USD","BK4608","LU0345769631.USD","LU0072462426.USD","IE00BDCRKT87.USD","LU0320765059.SGD","BK4554","LU2111349929.HKD","ADBE","FBX","LU0964807845.USD","LU1934455277.USD","LU2028103732.USD","SG9999015341.SGD","SG9999015986.USD","LU2430703178.SGD","TRUP","LU0466842654.USD","LU2092937148.SGD","LU2213496289.HKD","LU0256863902.USD","LU2471134879.HKD","BK4549","BSX","LU2506951792.HKD","METQ","LU2237438978.USD","LU1861558580.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU0106261372.USD","CHAT","LU0528227936.USD","LU1400636574.HKD","LU1718418525.SGD","LU1934455194.USD","IE00BYXW3230.USD","LU0942090050.USD","LU0225283273.USD","LU0323239441.USD","PTIR","LU0323240290.USD","SG9999001176.SGD","IE00B19Z3581.USD","LU2148611432.USD","SMH","LU0048584097.USD","BK4605","LU0683600562.USD","META","LU0553294199.USD","LU1291159041.SGD","LU1548497426.USD","LU1935042215.USD","IE00BKDWB100.SGD","SG9999000418.SGD","HK0000320264.USD","WISE","BK4107","LU2237443382.USD","FBL","LU0308772762.SGD","LU1823568750.SGD","LU2543165471.USD","IE00B19Z9P08.USD","LU0097036916.USD","LU2108987350.USD","LU1400636491.USD","LU1941712264.USD","SG9999017495.SGD","IE00B3SWFQ91.USD","LU1119994496.HKD","BK4598","PLTI","SG9999002224.SGD","LU1670711123.USD","BK4547","LU1691799644.USD","LU1992135399.USD","BK4527","LU0979878070.USD","LU1116320737.USD","LU1244550577.SGD","NOWX","LU2552382215.SGD","LU1923622291.USD","LU2271345857.HKD","SG9999015358.SGD","LU1670710588.SGD","LU0052756011.USD","LU2106854487.HKD","LU1629891620.HKD","NVDW","SG9999001077.SGD","BK4097","LU1236620834.HKD","LU1868837136.USD","LU1043141396.HKD","LU2125909593.SGD","IE00BK4W5L77.USD","LU2764263039.SGD","LU0545039389.USD","LU2360106780.USD","LU0345768740.USD","LU1153585028.USD","LU0949170772.SGD","HK0000320223.HKD","LU1232071149.USD","LU2592432038.USD","THMR","XDAT","LU0274383776.USD","LU2347655156.SGD","PLT","IE0034235295.USD","LU1057294990.SGD","SG9999018857.SGD","LU1861220033.SGD","LU2089283258.USD","HK0000306685.HKD","IE00BD6J9T35.USD","IE0009G5SDU7.USD","LU0070217475.USD","LU0080751232.USD","LU2133065610.SGD","LU1069344957.HKD","BK4567","LU1880398554.USD","IE00BZ9MQY76.HKD","SG9999001176.USD","LU1035775433.USD","SGXZ31699556.SGD","BK4543","SG9999014575.USD","BK4507","LU2417539215.USD","LU2458330243.SGD","LU2413666426.HKD","SHLD","3NVD.UK","IE00BWXC8680.SGD","IE00BQXX3C00.GBP","IE00BMPRXQ63.HKD","LU0154236417.USD","LU0072461881.USD","SG9999015945.SGD","NVDU","IE000YTNTUN2.SGD","LU1670756490.USD","IE0001KFT4U8.USD","LU0266013472.USD","CLOD","IETC","IXN","LU1261432733.SGD","LU1868836914.USD","LU1201861249.SGD","IE00BFXG0V08.USD","LU2750360997.AUD","LU1323610961.USD","LU1633808545.USD","LU1084165304.USD","LU1366333091.USD","LU2125909916.SGD","NVII","FTEC","LU2125909247.SGD","LU2211815571.USD","PLTG","CRM","LU0823414478.USD","NVDS","LU1242518931.SGD","LU1551013425.SGD","LTL","HK0000819398.USD","LU1935043536.SGD","NVD3.UK","LU1861127337.USD","LU0795875086.SGD","LU1989772840.SGD","BHVN","LU0127658192.USD","LU0985489474.SGD","LU2237443895.HKD","IE00BJT1NW94.SGD","IE00BJTD4V19.USD","NVDO","TRUC","LU2505996509.AUD","LU2087621335.USD","LU0208291251.USD","IE00B2B36J28.USD","METD","LU1670627923.USD","IE00BN29S564.USD","LU2247934214.USD","LU0029864427.USD","LU0432979614.USD","BBWI","LU2403377893.USD","NVDL","LU0726765562.USD","LU0122379950.USD","LU0149725797.USD","LU1868836591.USD","IE00BJJMRX11.SGD","LU1880398471.USD","LU2360107168.USD","LU1316542783.SGD","LU1066051225.USD","LU1674673428.USD","LFGY","LU0138981039.USD","IE000WAW04H5.SGD","LU0276348264.USD","LU2023250330.USD","IE0034235188.USD","LU2506952097.USD","LU0096362180.USD","LU2249611893.SGD","BK4534","NVIW.SI","LU0320765489.SGD","LU2756315318.SGD","LU0251131958.USD","LU0174119429.USD","LU0994945656.USD","LU1066051811.HKD","LU0788109477.HKD","LU0912757837.SGD","LU1244550494.USD","BK4607","LU2063271972.USD","GUNZ","LU0345770993.USD","LU0162691827.USD","LU1429558221.USD","LU2065171402.SGD","LU2087625088.SGD","LU2210150020.SGD","LU2317271919.USD","IE0002141913.USD","LU0354030438.USD","LU0661504455.SGD","NOW","NVDX","RSPC","SGXZ51526630.SGD","LU0012050646.USD","NVYY","LU1914381329.SGD","LU1202635105.USD","LU2237443549.SGD","BK4529","LU1267930730.SGD","LU1400636657.SGD","GAMR","LU2404859667.USD","LU1144417596.USD","LU0738911758.USD","LU1093756325.SGD","LU1951198990.SGD","LU2954938101.SGD","LU1564329115.USD","LU2462591350.SGD","LU1267930227.SGD","LU0109392836.USD","LU0882574055.USD","TRFK","LU0157215616.USD","LU2452424414.USD","BK4161","LU1037948541.HKD","FCOM","LU1093756168.USD","LU2237443622.USD","LU0265550946.USD","LU0205193047.USD","LU0251132253.USD","LU2420271590.USD","IE00BJLML261.HKD","BK4505","LU2458330169.SGD","LU1035773651.USD","LU1074936037.SGD","LU0170899867.USD","IE0009355771.USD","LU0354030511.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","LU2361045086.USD","SNVD.UK","LU2506951875.HKD","LU0203202063.USD","LU0820561909.HKD","LU2168564495.EUR","LU1043141123.HKD","LU0784384876.USD","LU0985320562.USD","LU0130103400.USD","IE00BZ1G4Q59.USD","2NVD.UK","LU1280957306.USD","LU2720916845.USD","LU2462591277.SGD","CMAG","LU2463028550.USD","LU2077746001.SGD","IE000W1ABFV2.USD","SNVDAmain","SPLTRmain","IE00B19Z9Z06.USD","LU0965508806.USD","LU1989772923.USD","LU0342679015.USD","LU2097344431.USD","LU2272731600.USD","SGXZ81514606.USD","LU2552382132.HKD","LU0061475181.USD","LU0823414551.USD","ANV","LU2097829019.USD","LU2506951958.HKD","SG9999001424.SGD","LU2462157665.USD","CLSE","LU1712237335.SGD","LU0672654240.SGD","LU1868836757.USD","BK4550","LU1989764748.USD","LU2362541273.HKD","LU2746668461.USD","SHOC","LU0690374615.EUR","GXPC","SGXZ99366536.SGD","LU0068578508.USD","LFSC","LU0128525929.USD","SG9999014559.SGD","IE00B4YYXB79.USD","SMTG","LU2506952170.USD","LU0477156797.USD","LU1064131342.USD","LU1435385759.SGD","IE00B7KXQ091.USD","BK4566","HK0000914660.USD","BK4579","LU2357305700.SGD","LU0070302665.USD","BK4588","IE000BZT7R73.USD","LU1037948897.HKD","LU1121112475.USD","LU2125154935.USD","LU2360032135.SGD","LU0648001328.SGD","LU1821325948.USD","LU0868494617.USD","LU1670711040.USD","LU0081259029.USD","LU2089284900.SGD","IE00B775H168.HKD","LU0648000940.SGD","LU0957791311.USD","LU0889566641.SGD","LU2357125470.USD","LU0210533765.USD","SG9999015952.SGD","LU0205194284.USD","SMHX","SG9999014880.SGD","LU0426412945.USD","PLYY","LU0048573561.USD","LU2471134952.CNY","LU1066053197.SGD","IE00B4JS1V06.HKD","LU2236285917.USD","CNEQ","USXF","LU2047632596.USD","IE0004086264.USD","LU2242650005.HKD","LU1935042488.USD","LU0314104364.USD","BK4528","LU0784385170.HKD","LU2324357040.USD","BK4524","LU0784383803.USD","METV","NVDQ","LU1720051108.HKD","LU0353189680.USD","NVDB","IE00B3S45H60.SGD","LU2931357623.SGD","PLTY","AGOX","IE0003U64NQ7.SGD","IE00B19Z3B42.SGD","IE00B5949003.HKD","SG9999014542.SGD","PLTA","IE000MB6IJN5.SGD","LU0820562030.AUD","LU1974910355.USD","LU0310799852.SGD","DCI","BK4077","GB00BDT5M118.USD","BK4504","PLOO","HK0000914686.HKD","LU2756315664.SGD","IE0002270589.USD","SPTE","SG9999014898.SGD","LU0345774631.USD","XLK","LU0868494708.USD","LU0889565833.HKD","GB00B4QBRK32.GBP","IE0004445239.USD","LU1116320901.HKD","LU0823417737.USD","LU0786609619.USD","LU0878866978.SGD","ESLG","SG9999002232.USD","LU2272731865.HKD","IE00B775SV38.USD","LU0251142724.SGD","LU2294711713.HKD","LU1623119135.USD","CHPX","LU2487616109.SGD","LU1267930573.SGD","LU2860962120.EUR","ARTY","LU2168564149.EUR","LU0210528500.USD","HK0000306701.USD","LU0390134368.USD","LU0011850046.USD","LU1301847155.USD","LU0310800379.SGD","LU2473716301.USD","TTEQ","LU0795875169.SGD","LU1059921491.USD","HK0000532082.HKD","LU0128525689.USD","NVD","VGT","LU2322448957.HKD","LU1951200564.SGD","LU1003077747.HKD","LU2065171311.SGD","NVD2.UK","IE00B5TLWC47.USD","BK4614","FDTX","LU2430703251.USD","SG9999004303.SGD","ZM","LU1244550221.USD","LU2237443465.HKD","LU1267930813.SGD","07788","LU2461242641.AUD","LU2896262040.SGD","IE000KEQY171.SGD","LU0395794307.EUR","LU0310800965.SGD","LU1721428933.USD","LU0345770308.USD","LU1804176565.USD","LU1551013342.USD","BK4503","LU0949170426.SGD","LU2413666699.HKD","AIFD","NVDD","LU2065169927.USD","LU0130517989.USD","NVDY","LU0742534661.SGD","LU0094547139.USD","BK4538","IE00B19Z9505.USD","LU1868837300.USD","LU1489326972.SGD","LU2244417387.USD","LU0079474960.USD","LU1496350171.SGD","LU2237443978.SGD","LU2491050071.SGD","LU1861215975.USD","LU0316494557.USD","PLTR","BK4535","LU1564329032.USD","LU0792757196.USD","NVDA","LU0433182093.SGD","LU0238689110.USD","IE00BDRTCR15.USD","LU2322448791.USD","LU0215105999.USD","LU0472753341.HKD","BK4587","LU1988902786.USD","BK4613","LU0056508442.USD","LU2168563687.JPY","SOXY","FBY","PLTD","LU0107464264.USD","SGXZ57979304.SGD","LU0444971666.USD","BK4548","LU0203345920.USD","LU2023251221.USD","DIPS","FBYY","LU1852331112.SGD","LU1571399168.USD","IE00BQXX3D17.EUR","LU2168564065.EUR","LU2290526834.HKD","LU0289961442.SGD","LU1235294995.USD","BK4023","LU1366192091.USD","LU1791710400.SGD","LU1201861165.SGD","LU2381873111.SGD","EYES","LU0234570918.USD","LU1023059063.AUD","LU2272731782.SGD","LU2456880835.USD","IE00B894F039.SGD","SG9999015978.USD","LU2265009873.SGD","LU2637965513.SGD","LU0323591593.USD","LU1697837992.HKD","LU1815333072.USD","LU1496350502.SGD","LU0143551892.USD","LU0069063385.USD","LU1992135472.HKD","LU0054578231.USD","LU1941712348.USD","LU0256863811.USD","LU2750360641.GBP","SG9999014906.USD","NULC","LU1815336760.USD","TYLG","IE0004091025.USD","LU2210149790.SGD","IE00B4R5TH58.HKD","LU2552382058.USD","IE00BHPRN162.USD","IE0005OL40V9.USD","LU2095319765.USD","LU0823421416.USD","ILDR","LU1564329628.SGD","LU0708995401.HKD","BK4551","LU1989771016.USD","IE00BKPKM429.USD","LU0130102774.USD","IE00BFTCPJ56.SGD","LU1814569148.SGD","LU2054465674.USD","LU2279689827.SGD","LU2361044949.HKD","IE00BJTD4N35.SGD","LU1061106388.HKD","LU1670710661.SGD","LU2112291526.USD","SMETAmain","LU0957808578.USD","IE00BK4W5M84.HKD","LU1983260115.SGD","LU0642271901.SGD","LU2168564222.USD","LU0175139822.USD","LU1069347547.HKD","XLC","LU0082616367.USD","LU1803068979.SGD","SNPE","IE00B1BXHZ80.USD","LU0708994859.HKD","LU0552385451.USD","NOWL","ABFL","BK4533","LU0345768153.USD","LU2237957811.SGD","LU2362541513.USD","LU0689626769.HKD","LU0823421333.USD","LU0557290698.USD","METU","LU1645745479.HKD","LU0289960550.SGD","LU1935043023.USD","LU1145028129.USD","IGV","LU2347655073.USD","IE0034235303.USD","LU0980610538.SGD","HK0000304805.HKD","LU0347712357.USD","LU0289739343.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662164967","title":"Spyre Therapeutics (SYRE) Gets a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662164967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662164967?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:55","pubTimestamp":1787745337,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics, with a price target of $116.00. Slutsky...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/spyre-therapeutics-syre-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/spyre-therapeutics-syre-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SYRE","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662239718","title":"Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662239718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662239718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:50","pubTimestamp":1787741417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Solventum Corporation (SOLV), Argenx Se (ARGX) and S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","HCSG","XLV","LU0109394709.USD","IE0034235188.USD","IE00BJT1NW94.SGD","SYRE","LU0823416689.USD","BK4198","LU1983260115.SGD","IE0009355771.USD","SOLV","IE0002141913.USD","XBI","IE00BJJMRZ35.SGD","LABU","LU2324357040.USD","LU0029874061.USD","ARGX","TBXU","BK4505","LFSC","BK4588","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4585","BK4581","FMED","BK4137","LU0320765992.SGD","LU0889565916.HKD","IBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662979105","title":"Spyre Therapeutics Reports Phase 2 Skyway RA Data for Spy072 Shows Statistically Significant Benefit vs Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2662979105","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662979105?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:30","pubTimestamp":1787736639,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics reports Phase 2 SKYWAY RA data for SPY072 shows statistically significant benefit vs placeboSpyre Therapeutics reported topline Phase 2 SKYWAY rheumatoid arthritis sub-study results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2xmQmj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662799910","title":"Spyre Therapeutics Shares Down 12.4% Premarket After Co's Experimental Drug Fails to Meet Threshold for Monotherapy Development in Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2662799910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662799910?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:57","pubTimestamp":1787734667,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N0KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LFSC","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760351","title":"Circio and Full Circles join forces on non-viral in vivo cell therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760351?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:43","pubTimestamp":1787723005,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA and Full Circles Therapeutics have entered a research collaboration t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","BK4585","FBT","CNCR","IBBQ","IBB","TBXU","LFSC","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762356","title":"Spyre Therapeutics Inc : Btig Cuts Target Price to $121 from $132","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762356?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:34","pubTimestamp":1787718880,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N05M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SYRE","LFSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662768622","title":"Stocks to Watch: Intuit, Spyre Therapeutics, Zoom Communications, nCino","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662768622?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:05","pubTimestamp":1787699100,"startTime":"0","endTime":"0","summary":"Intuit projected that sales growth would slow in the year ahead, weighed down by expected declines in the company's desktop business. The company may also accept short-term trade-offs in its business as it looks to boost TurboTax customers, its CFO told The Wall Street Journal. Shares fell 9.8% to $322.57 in after-hours trading on Tuesday.Spyre Therapeutics said it will not prioritize developing one of its drug candidates as a monotherapy for rheumatoid arthritis after results from a trial missed its internal targets. The stock slid 11% to $95.09 after the bell.Zoom Communications issued guidance for third-quarter adjusted earnings per share that missed Wall Street expectations. Shares were down 3.9% at $97.00.NCino projected third-quarter revenue in a range with a midpoint below analyst expectations. The stock was down 5.6% at $19.65.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4532","SG9999002232.USD","INTU","LU1235294995.USD","LU0965509101.SGD","LU0158827948.USD","BK4567","BK4525","SYRE","BK4608","LU0011850046.USD","LU0965508806.USD","IE00B19Z8X17.USD","LU0965509283.SGD","LU2065171311.SGD","NCNO","LU0124676726.USD","LU0949170772.SGD","LU0965509010.AUD","LU1046421795.USD","BK4554","BK4551","LU1043141396.HKD","LU0957791311.USD","BK4533","LU2089284900.SGD","LFSC","SG9999001424.SGD","BK4585","LU0689626769.HKD","IE00BQXX3F31.USD","LU2095319765.USD","BK4534","LU1778281490.HKD","LU0289961442.SGD","LU1861559042.SGD","IE00B19Z8W00.USD","LU0097036916.USD","LU0640476718.USD","IE00BQXX3C00.GBP","LU0109392836.USD","IE00B5949003.HKD","LU1861558580.USD","LU1037948541.HKD","BK4023","LU0823434583.USD","LU1674673428.USD","LU1280957306.USD","LU1823568750.SGD","LU0061474960.USD","LU2065170008.USD","LU1037948897.HKD","BK4528","ZM","LU0266013472.USD","LU2089283258.USD","LU0661504455.SGD","LU2065171402.SGD","LU1815333072.USD","LU0289739343.SGD","LU1366333091.USD","LU2210149790.SGD","LU1236620750.USD","LU1803068979.SGD","LU0426417589.USD","LU0157215616.USD","LU0861579265.USD","LU1934455194.USD","BK4505","LU0738911758.USD","LU2265009873.SGD","LU0342679015.USD","LU2023251221.USD","LU0426412945.USD","LU1121112475.USD","BK4588","LU1934455863.HKD","LU0082616367.USD","IE0009356076.USD","BK4613","LU1236620834.HKD","LU0889565833.HKD","GB00BDT5M118.USD","BK4139","IE00B19Z9505.USD","LU0994945656.USD","LU0511384066.AUD","LU1934455277.USD","LU2063271972.USD","IE00BQXX3D17.EUR","LU0823434740.USD","BK4548","SG9999002224.SGD","LU0719512351.SGD","LU1804176565.USD","BK4535","LU1674673691.USD","LU2065169927.USD","LU0345774391.USD","LU1043141123.HKD","LU0345774631.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776851","title":"Spyre Therapeutics Stock (SYRE) Tumbles 14% in After-Hours – Here’s What Spooked Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776851?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:51","pubTimestamp":1787698276,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics ($SYRE) fell as much as 14% in after‑hours trading on Tuesday after the company said it will stop developing its rheumatoid arth...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/spyre-therapeutics-stock-syre-tumbles-14-in-after-hours-heres-what-spooked-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/spyre-therapeutics-stock-syre-tumbles-14-in-after-hours-heres-what-spooked-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LFSC","ISBC","SYRE","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662675221","title":"Spyre Therapeutics Won't Prioritize Rheumatoid Arthritis Monotherapy After Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662675221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662675221?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics will not prioritize the use of its SPY072 drug candidate as a monotherapy to treat rheumatoid arthritis, saying that results from a phase 2 trial did not meet the company's threshold.Shares of the biotechnology company fell on the news, losing 13% in after-hours trading to $93.50.A substudy of the drug to treat rheumatoid arthritis, part of a broader phase 2 study focusing on rheumatic diseases, showed that high and low doses both had statistically significant benefits over a placebo on certain endpoints, Spyre said. The low dose demonstrated a statistically significant benefit on the study's primary endpoint, the company added.But the magnitude of the results missed the company's targets, it said.\"The results provide proof-of-mechanism for TL1A in RA and support its potential in other autoimmune diseases and as a combination component, but did not meet the Company's internal bar to prioritize advancement of SPY072 in RA,\" the company said. SPY072 is designed to inhi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SYRE","BK4007","BK4139","LFSC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754700","title":"Spyre Therapeutics announces results from RA sub-study of SKYWAY basket trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754700?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:05","pubTimestamp":1787688312,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics (SYRE) announced results from the RA sub-study of its Phase 2 SKYWAY basket trial evaluating SPY072 in rheumatic diseases. Both ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-announces-results-from-ra-sub-study-of-skyway-basket-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-announces-results-from-ra-sub-study-of-skyway-basket-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4007","LFSC","SYRE","RA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662981754","title":"Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-Study of the Skyway Phase 2 Trial of Spy072","url":"https://stock-news.laohu8.com/highlight/detail?id=2662981754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662981754?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:01","pubTimestamp":1787688060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA3HCVK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}